Source: Health Canada shortage reports · Updated Oct 16, 2026
Amlodipine Telmisartan is in a widespread shortage in Canada. 4 of 6 reported products are affected. The latest manufacturer estimate for full recovery is Jan 4, 2027.
A combination of a calcium channel blocker and an ARB used to lower high blood pressure.
Products affected
4 / 6
In shortage since
Oct 8, 2026
Est. full return
Jan 4, 2027
Reports on file
32
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
DIN 02371057 · ended Jan 28, 2021 · Disruption of the manufacture of the drug.
Showing 12 of 32 reports. All reports are on file with Health Canada.
What's happening
Amlodipine Telmisartan is currently affected by 4 active shortage reports filed with Health Canada by BOEHRINGER INGELHEIM (CANADA) LTD LTEE, AA PHARMA INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Amlodipine Telmisartan is classified under “ANGIOTENSIN II ANTAGONISTS, COMBINATIONS” (ATC C09DB).
Recent changes
Oct 16, 2026
Status changed
Oct 13, 2026
Status changed
Sep 28, 2026
Shortage resolved
Sep 21, 2026
New report filed
Sep 21, 2026
Estimated end date moved earlier : Feb 1, 2027 → Sep 21, 2026
Sep 21, 2026
New report filed
Sep 21, 2026
New report filed
Sep 21, 2026
New report filed
Common questions
What is Amlodipine Telmisartan used for?
A combination of a calcium channel blocker and an ARB used to lower high blood pressure.
When will Amlodipine Telmisartan be back in stock in Canada?
The latest manufacturer estimate is Jan 4, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Amlodipine Telmisartan in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.